Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnbio Biotechnology Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/07/2026 | Q4 2025 | N/A | $0.07 | N/A | N/A | $4.74 M |
| 06/29/2025 | Q2 2025 | N/A | $0.09 | N/A | N/A | $5.01 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $2.53 M |
| 06/30/2024 | Q2 2024 | N/A | $0.09 | N/A | N/A | $6.32 M |
| 12/31/2023 | Q4 2023 | N/A | $0.02 | N/A | N/A | $3.95 M |
| 06/30/2023 | Q2 2023 | N/A | $0.04 | N/A | N/A | $3.31 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anbio Biotechnology Earnings: FAQ's
The conference call for Anbio Biotechnology's latest earnings report can be listened to online.
The conference call transcript for Anbio Biotechnology's latest earnings report can be read online.
Anbio Biotechnology (:NNNN) has a recorded annual revenue of $9.76 M.
Anbio Biotechnology (:NNNN) has a recorded net income of $7.23 M.Anbio Biotechnology has generated $0.16 earnings per share over the last four quarters.
Anbio Biotechnology (:NNNN) has a price-to-earnings ratio of 100.61 and price/earnings-to-growth ratio is 1.01.